Recent Posts
- OKYO Pharma Announces Start of Phase 2 Clinical Trial to Treat Patients with Neuropathic Corneal Pain
- OKYO Pharma Announces Chairman Acquires Shares
- OKYO Pharma Announces Chairman Acquires Shares
- OKYO Pharma Granted U.S. Patent Covering OK-101’s Potential for Treating Symptoms of Dry Eye Disease
- OKYO Pharma CEO Interview to Air on Bloomberg TV
Recent Comments
No comments to show.